Literature DB >> 23328692

PERK-ing up autophagy during MYC-induced tumorigenesis.

Souvik Dey1, Feven Tameire, Constantinos Koumenis.   

Abstract

Stress in the tumor microenvironment in the form of hypoxia and low glucose/amino acid levels activates the evolutionarily conserved cellular adaptation program called the unfolded protein response (UPR) promoting cell survival in such conditions. Our recent studies showed that cell autonomous stress such as activation of the proto-oncogene MYC/c-Myc, can also trigger the UPR and induce endoplasmic reticulum (ER) stress-mediated autophagy. Amelioration of ER stress or autophagy enhances cancer cell death in vitro and attenuates tumor growth in vivo. Here we will discuss the role of the UPR and autophagy in MYC-induced transformation. Our findings demonstrate that the EIF2AK3/PERK-EIF2S1/eIF2α-ATF4 arm of the UPR promotes tumorigenesis by activating autophagy and enhancing tumor formation. Therefore, the UPR is an attractive target in MYC-driven cancers.

Entities:  

Keywords:  ATF4; Burkitt lymphoma; EIF2AK3/PERK; ULK1; c-Myc; unfolded protein response

Mesh:

Substances:

Year:  2013        PMID: 23328692      PMCID: PMC3627677          DOI: 10.4161/auto.23486

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  28 in total

Review 1.  Cellular and molecular mechanisms underlying oxygen-dependent radiosensitivity.

Authors:  Chao Liu; Qun Lin; Zhong Yun
Journal:  Radiat Res       Date:  2015-05-04       Impact factor: 2.841

2.  The UPR preserves mature oligodendrocyte viability and function in adults by regulating autophagy of PLP.

Authors:  Sarrabeth Stone; Shuangchan Wu; Klaus-Armin Nave; Wensheng Lin
Journal:  JCI Insight       Date:  2020-03-12

3.  Type I interferons mediate pancreatic toxicities of PERK inhibition.

Authors:  Qiujing Yu; Bin Zhao; Jun Gui; Kanstantsin V Katlinski; Angela Brice; Yan Gao; ChangHong Li; Jake A Kushner; Constantinos Koumenis; J Alan Diehl; Serge Y Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-01       Impact factor: 11.205

4.  Regulatory module involving FGF13, miR-504, and p53 regulates ribosomal biogenesis and supports cancer cell survival.

Authors:  Débora R Bublik; Slađana Bursać; Michal Sheffer; Ines Oršolić; Tali Shalit; Ohad Tarcic; Eran Kotler; Odelia Mouhadeb; Yonit Hoffman; Gilad Fuchs; Yishai Levin; Siniša Volarević; Moshe Oren
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-19       Impact factor: 11.205

5.  The PKR-Like Endoplasmic Reticulum Kinase Promotes the Dissemination of Myc-Induced Leukemic Cells.

Authors:  Jun Gui; Kanstantsin V Katlinski; Constantinos Koumenis; J Alan Diehl; Serge Y Fuchs
Journal:  Mol Cancer Res       Date:  2019-03-22       Impact factor: 5.852

6.  Concerted Action of PGC-1-related Coactivator (PRC) and c-MYC in the Stress Response to Mitochondrial Dysfunction.

Authors:  Natalie Gleyzer; Richard C Scarpulla
Journal:  J Biol Chem       Date:  2016-10-27       Impact factor: 5.157

7.  Reduced expression of MYC increases longevity and enhances healthspan.

Authors:  Jeffrey W Hofmann; Xiaoai Zhao; Marco De Cecco; Abigail L Peterson; Luca Pagliaroli; Jayameenakshi Manivannan; Gene B Hubbard; Yuji Ikeno; Yongqing Zhang; Bin Feng; Xiaxi Li; Thomas Serre; Wenbo Qi; Holly Van Remmen; Richard A Miller; Kevin G Bath; Rafael de Cabo; Haiyan Xu; Nicola Neretti; John M Sedivy
Journal:  Cell       Date:  2015-01-22       Impact factor: 41.582

Review 8.  Targeting the unfolded protein response in cancer.

Authors:  Rani Ojha; Ravi K Amaravadi
Journal:  Pharmacol Res       Date:  2017-04-08       Impact factor: 7.658

9.  PERK Activation Promotes Medulloblastoma Tumorigenesis by Attenuating Premalignant Granule Cell Precursor Apoptosis.

Authors:  Yeung Ho; Xiting Li; Stephanie Jamison; Heather P Harding; Peter J McKinnon; David Ron; Wensheng Lin
Journal:  Am J Pathol       Date:  2016-05-12       Impact factor: 4.307

Review 10.  Targeting autophagy in lymphomas: a double-edged sword?

Authors:  Han Zhang
Journal:  Int J Hematol       Date:  2018-01-27       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.